[1]
Mesyasz, M. et al. 2026. Teprotumumab as a Breakthrough in Thyroid Eye Disease Therapy: A Comprehensive Review. Quality in Sport. 49, (Jan. 2026), 67295. DOI:https://doi.org/10.12775/QS.2026.49.67295.